Orthogonal P-wave morphology, conventional P-wave indices, and the risk of atrial fibrillation in the general population using data from the Finnish Hospital Discharge Register.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 11 01 2020
accepted: 23 04 2020
pubmed: 20 6 2020
medline: 29 6 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Identifying subjects at high and low risk of atrial fibrillation (AF) is of interest. This study aims to assess the risk of AF associated with electrocardiographic (ECG) markers linked to atrial fibrosis: P-wave prolongation, 3rd-degree interatrial block, P-terminal force in lead V1, and orthogonal P-wave morphology. P-wave parameters were assessed in a representative Finnish population sample aged ≥30 years (n = 7217, 46.0% male, mean age 51.4 years). Subjects (n = 5489) with a readable ECG including the orthogonal leads, sinus rhythm, and a predefined orthogonal P-wave morphology type [positive in leads X and Y and either negative (Type 1) or ± biphasic (Type 2) in lead Z; Type 3 defined as positive in lead X and ± biphasic in lead Y], were followed 10 years from the baseline examinations (performed 1978-80). Subjects discharged with AF diagnosis after any-cause hospitalization (n = 124) were defined as having developed AF. Third-degree interatrial block was defined as P-wave ≥120 ms and the presence of ≥2 ± biphasic P waves in the inferior leads. Hazard ratios (HRs) and confidence intervals (CIs) were assessed with Cox models. Third-degree interatrial block (n = 103, HR 3.18, 95% CI 1.66-6.13; P = 0.001) and Type 3 morphology (n = 216, HR 3.01, 95% CI 1.66-5.45; P < 0.001) were independently associated with the risk of hospitalization with AF. Subjects with P-wave <110 ms and Type 1 morphology (n = 2074) were at low risk (HR 0.46, 95% CI 0.26-0.83; P = 0.006), compared to the rest of the subjects. P-wave parameters associate with the risk of hospitalization with AF.

Identifiants

pubmed: 32556298
pii: 5859182
doi: 10.1093/europace/euaa118
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1173-1181

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Antti Eranti (A)

Heart Center, Central Hospital of North Karelia, Tikkamäentie 16, 80210 Joensuu, Finland.

Jonas Carlson (J)

Department of Cardiology, Lund University, Entrégatan 7, 22185 Lund, Sweden.

Tuomas Kenttä (T)

Research Unit of Internal Medicine, Medical Research Center, Oulu University Hospital and University of Oulu, Kajaanintie 50, 90220 Oulu, Finland.

Fredrik Holmqvist (F)

Department of Cardiology, Center for Integrative Electrocardiography, Clinical Sciences at Lund University and Arrhythmia Clinic, Skåne University Hospital, Entrégatan 7, 22185 Lund, Sweden.

Arttu Holkeri (A)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland.

M Anette Haukilahti (MA)

Research Unit of Internal Medicine, Medical Research Center, Oulu University Hospital and University of Oulu, Kajaanintie 50, 90220 Oulu, Finland.

Tuomas Kerola (T)

Department of Internal Medicine, Päijät-Häme Central Hospital, Keskussairaalankatu 7, 15850 Lahti, Finland.

Aapo L Aro (AL)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland.

Harri Rissanen (H)

Department of Public Health Solutions, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00271 Helsinki, Finland.

Kai Noponen (K)

Center for Machine Vision and Signal Analysis, University of Oulu, Pentti Kaiteran katu 1, 90014 Oulu, Finland.

Tapio Seppänen (T)

Center for Machine Vision and Signal Analysis, University of Oulu, Pentti Kaiteran katu 1, 90014 Oulu, Finland.

Paul Knekt (P)

Department of Public Health Solutions, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00271 Helsinki, Finland.

Markku Heliövaara (M)

Department of Public Health Solutions, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00271 Helsinki, Finland.

Heikki V Huikuri (HV)

Research Unit of Internal Medicine, Medical Research Center, Oulu University Hospital and University of Oulu, Kajaanintie 50, 90220 Oulu, Finland.

M Juhani Junttila (MJ)

Research Unit of Internal Medicine, Medical Research Center, Oulu University Hospital and University of Oulu, Kajaanintie 50, 90220 Oulu, Finland.

Pyotr G Platonov (PG)

Department of Cardiology, Center for Integrative Electrocardiography, Clinical Sciences at Lund University and Arrhythmia Clinic, Skåne University Hospital, Entrégatan 7, 22185 Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH